We advised the underwriters on the SPAC IPO and Nasdaq listing

Davis Polk advised the underwriters in connection with the $276 million initial public offering of 27,600,000 units of Priveterra Acquisition Corp., which includes 3,600,000 units from the full exercise of the underwriters’ over-allotment option to purchase additional units. Each unit consists of one common share and one redeemable warrant to purchase one-third common share of Priveterra Acquisition Corp. The units were listed on the Nasdaq Capital Market under the symbol “PMGMU.”

Priveterra Acquisition Corp. is a newly organized, special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. As such, Priveterra Acquisition Corp. intends to pursue prospective targets on the medical technology sector.

The Davis Polk corporate team included partner Derek Dostal and associate Ernesto Talamas Velazquez. The tax team included counsel Kiara L. Rankin and associate Rebecca A. Rosen. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.